Discover how our research collaboration with UltraSpec Lab and our own Dovita manufacturing facility connect ingredient choices, product development and quality records.
Representative laboratory research imagery · Edward Jenner / Pexels.
AIDEVI
Product direction, formulation story and customer information.
UltraSpec Lab
Research collaboration, analytical capabilities and computational methods.
Dovita Nutrition
Our own manufacturing facility, production and quality documentation.
The people and disciplines behind our research network
UltraSpec Lab: our research collaboration
AIDEVI works with UltraSpec Lab on its science and product-development direction. The Canadian laboratory describes capabilities in bioinformatics, applied chemistry, supplement analysis and research services. Its official website includes AIDEVI among its published major partners.
The collaboration brings together complementary disciplines: sample and analytical work, computational methods, data interpretation and translation into usable product formats. These roles connect an ingredient idea with the questions that need experimental and manufacturing follow-up.
Research partner Laboratory and computational research
Research background highlighted in partner materials
180+
SCI publications
4,000+
Citations
35
H-index
Research figures reported in AIDEVI’s partner profile and in published collaboration materials. They describe the research background presented for the partner network, rather than the number of human trials conducted on AIDEVI products.
Biochemistry and analysis
Sample handling, analytical methods and interpretation of material specifications. The method and tested sample matter as much as the headline result.
Algorithms and modeling
Computational approaches to biological questions and candidate selection. Model predictions inform questions that still require experimental evaluation.
Data and evidence review
Interpretation of study populations, controls, endpoints and limitations, keeping ingredient research distinct from finished-formula findings.
Product translation
Connection of formulation choices with dosage form, production feasibility, labeling and the documentation customers need to make informed choices.
Documented academic project
Hosna Jabbari · University of Victoria
Mitacs lists Hosna Jabbari as the faculty supervisor of its DNA-methylation biological-age prediction project, with UltraSpec Lab as the partner company and the University of Victoria as the university. This provides a specific public example of the laboratory’s academic collaboration.
The published role concerns this University of Victoria–UltraSpec research project and its biological-age prediction objective.
Research directions, with a clear link to the evidence
Healthy-aging research spans different levels, from molecular mechanisms to measurements in people. Our research collaboration connects these directions with practical questions about ingredient selection, formula design and product evaluation.
Visual from UltraSpec’s research page. It illustrates a research direction; it is not an AIDEVI clinical result or proof of absorption.
Bioinformatics and metabolic modeling
UltraSpec describes work on metabolic-network modeling and AI-supported simulation. Such tools can help explore biological relationships and prioritize hypotheses. A predicted interaction or uptake rate needs an appropriate experiment before it becomes a product claim.
Epigenetics and biological-age research
The Mitacs project examines DNA-methylation patterns as a basis for biological-age prediction. This establishes a research topic and collaboration, rather than evidence that an AIDEVI supplement reduces biological age.
Analytical testing and material characterization
The laboratory’s published services include ingredient identification, contaminants, microbiology, stability and dissolution-related work. A service portfolio describes available capabilities; a particular product’s testing coverage is established by its matching report.
UltraSpec also describes nanomedicine research on its project page. Its relevance here is the broader study of delivery systems. Pharmaceutical nanocarrier findings do not establish that an oral AIDEVI supplement uses the same technology or produces the same outcomes.
Start with the ingredient, then examine the formula.
See the research in actual product development files
A clear formulation story explains why ingredients were selected, what was evaluated and what remains uncertain. Our product development files provide two concrete examples you can review in more detail.
NR-centered formulation
NAD+ SUSTAIN
The development report explains the roles of NR Malate and complementary ingredients. It includes a short-term cell assay and a 28-day, open-label study in 30 healthy women, with skin-related measurements.
The cell experiment concerns intracellular NAD+ in its stated model. The consumer study has no placebo group or blinding. These records make the research assessable, while leaving human absorption and long-term outcomes as separate questions.
The development report links its ingredient and delivery-format rationale to a 56-day, open-label, self-controlled study in 34 healthy women. Assessments include skin mechanics, wrinkle topography and dermal imaging signals.
The findings describe observations under that protocol. Without a blinded placebo comparison, they do not establish that the formula alone caused the changes or that the same results apply to every user.
Read the formulation, study design and limitations together. Ingredient purity data, cell experiments and human measurements answer different questions.
Our approach: explain the decision behind the formula
A defined ingredient role
A broader formula should explain what each active contributes. Adding more ingredients is not, by itself, evidence of a better result.
A suitable product format
Capsules, powders and liquids serve different practical needs. Delivery claims should connect to formulation-specific dissolution, stability or absorption evidence.
An evidence level that readers can see
A useful research explanation names the model or population, measured endpoint and comparison. It also makes the limits of interpretation understandable.
Our aim is to give healthy-aging formulas a clear scientific rationale and an understandable evidence record. Research should help people ask better questions about a product, alongside its label, quality information and fit within an everyday wellness routine.
Dovita Nutrition Health, LLC is AIDEVI’s own manufacturing facility in Rancho Cucamonga, California. Bringing formulation development and production into the same product pathway supports a direct connection between ingredient choices, manufacturing feasibility and quality documentation.
Its manufacturing capabilities span hard capsules, softgels, gummies, liquids, powders and tablets. The format selected for a particular formula should be understood alongside its ingredients, serving information and product-specific development record.
Manufacturing quality depends on documented specifications and controls, including ingredient acceptance, production and packaging records, applicable testing and batch review. For dietary supplements, cGMP addresses manufacturing operations; it is separate from clinical evidence about a formula’s effects.
For a specific product, check the production entity and site named in the relevant record. Manufacturing ownership, a facility certificate and a finished-product test result are distinct pieces of information.
From formulation question to batch documentation
These six stages show how the development story connects with manufacturing and quality records. They provide a practical way to review a product, while keeping research findings and batch-release information in their proper context.
01
Define the formulation question
Identify the wellness direction and explain the intended role of each ingredient. The published product development file is the starting point for reviewing this rationale.
02
Review ingredient documentation
Connect identity and material specifications with the relevant supplier and lot. A raw-material purity result applies to that tested material; it is not automatically a finished-product result.
03
Evaluate format and feasibility
Consider ingredient compatibility, product format and stability or dissolution questions. A delivery-system explanation should be supported by the evidence relevant to that formula.
04
Connect the formula with production records
Identify the manufacturing site, dosage form and production documentation. Facility credentials should be matched to their holder, activities and stated period.
05
Read sample-specific test results
Check the named product or sample, laboratory or issuer, date, parameters and methods. When independent testing is claimed, identify the external laboratory and report.
06
Match the documents to the batch
Use the exact product and lot code to connect a bottle with available quality records. Ask for the applicable document if the public example covers another product or lot.
Qualifications and reports you can review
Our quality certificates and COA guide organizes published manufacturing records by named holder, site, scope and dates. It also distinguishes facility qualifications from product and batch records, so you can review the type of evidence relevant to your question.
Health Canada Certified*
*Qualification wording in AIDEVI’s partner profile. The public Health Canada reference lists UltraSpec Lab Ltd. as licence holder of GLOWING, NPN 80129076. That record is for the named product; it does not itself establish laboratory certification or approval of AIDEVI products.
A COA connects to a named product and lot
The example shown here is the published Dovita-issued NMN18000 COA for lot 01AN17532616, dated 5 November 2025. Its issuer, methods and listed results need to be read together. It should not be described as an independent laboratory report simply because it is titled Certificate of Analysis.
AIDEVI works with UltraSpec Lab as its research collaboration. Public materials describe the laboratory’s analytical and computational capabilities, and its website displays AIDEVI among its partners. Our product development files provide formula-specific research context.
Is Dovita an outside contract manufacturer?
Dovita Nutrition Health, LLC is AIDEVI’s own manufacturing facility in California. For documentation questions, the exact entity, site and product or lot named in each record still matter.
Do AI models prove that a supplement works?
Models can help explore mechanisms and prioritize research questions. A prediction does not replace experimental validation or a suitable human study. Evidence about one ingredient or delivery method also needs to be distinguished from evidence about the complete formula.
Are there human studies in the published development files?
The NAD+ SUSTAIN file includes a 28-day open-label study, and the EGT 60MG file describes a 56-day open-label study. Read the participant group, measurements and study limitations in each report before interpreting the findings.
Does a research metric or qualification apply to every AIDEVI product?
Publication figures describe the partner profile in which they are reported. A qualification or licence applies to its stated holder and scope. Neither should be treated as proof that every finished formula has the same clinical evidence or testing coverage.
How can I obtain the record for my bottle?
Send the exact product name, lot/batch code, expiry date and purchase source to AIDEVI support. Specify whether you need a development file, facility qualification, COA or independent laboratory report. Availability and scope depend on the product and batch.
For ingredients, serving information and daily-use questions, continue to the supplement FAQ.
Partner profiles and further reading
The links below let you review the partner profiles and public records described here. Product studies and ingredient pages are linked beside their corresponding explanations. Source review: 14 October 2026.
Explore the AIDEVI product range, read the relevant development report, then check the product label and quality documentation. For a question about a particular formula or batch, include its name and lot number when you contact us.
Research findings should be interpreted within the sample, study design and methods reported. Individual results may vary. AIDEVI dietary supplements are not intended to diagnose, treat, cure or prevent disease.
